Header Logo

STEPHANIE FETZKO

Concepts (43)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rhabdomyosarcoma
2
2024
214
1.310
 Why?
Salvage Therapy
1
2024
200
0.790
 Why?
Neoplasm Recurrence, Local
3
2024
1305
0.700
 Why?
Hematologic Neoplasms
2
2023
295
0.680
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1342
0.530
 Why?
Neoplasms
1
2023
2956
0.290
 Why?
Rhabdomyosarcoma, Embryonal
1
2022
52
0.180
 Why?
Killer Cells, Natural
1
2023
347
0.170
 Why?
Soft Tissue Neoplasms
1
2022
129
0.170
 Why?
White Matter
1
2022
214
0.160
 Why?
Brain Diseases
1
2022
305
0.160
 Why?
Sarcoma
1
2022
208
0.160
 Why?
Diagnostic Imaging
1
2022
314
0.150
 Why?
Survival Rate
1
2024
2194
0.150
 Why?
Proportional Hazards Models
1
2022
1460
0.140
 Why?
3-Iodobenzylguanidine
1
2016
12
0.130
 Why?
Immunotherapy, Adoptive
1
2023
897
0.130
 Why?
Retrospective Studies
3
2024
17424
0.120
 Why?
Radiopharmaceuticals
1
2016
170
0.120
 Why?
Infant
4
2024
13064
0.120
 Why?
Follow-Up Studies
1
2024
5419
0.120
 Why?
Prognosis
1
2024
5014
0.110
 Why?
Neoplasms, Second Primary
1
2016
149
0.110
 Why?
Young Adult
3
2024
9961
0.110
 Why?
Child, Preschool
3
2024
14752
0.100
 Why?
Neuroblastoma
1
2016
550
0.090
 Why?
Adolescent
3
2024
20564
0.080
 Why?
Risk Factors
1
2024
10949
0.080
 Why?
Humans
6
2024
132132
0.080
 Why?
Antineoplastic Agents
1
2016
1825
0.060
 Why?
Child
2
2024
25791
0.060
 Why?
Adult
2
2024
31585
0.060
 Why?
Male
3
2024
64985
0.050
 Why?
Female
3
2024
70725
0.050
 Why?
Proto-Oncogene Proteins
1
2022
613
0.040
 Why?
Repressor Proteins
1
2022
812
0.030
 Why?
Seizures
1
2022
893
0.030
 Why?
Myelodysplastic Syndromes
1
2016
130
0.030
 Why?
Age of Onset
1
2016
622
0.030
 Why?
Biomarkers, Tumor
1
2022
1659
0.030
 Why?
Combined Modality Therapy
1
2016
1295
0.020
 Why?
Magnetic Resonance Imaging
1
2022
3833
0.020
 Why?
Risk Assessment
1
2016
3739
0.020
 Why?
FETZKO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (43)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_